Skip to main content
. Author manuscript; available in PMC: 2022 Sep 30.
Published in final edited form as: Alzheimers Dement. 2021 Dec 9:10.1002/alz.12528. doi: 10.1002/alz.12528

Table 3.

APOE genotypes and their association with AD and ADRD by sex in the Multiethnic Cohort Study (1999-2014; N = 16,016).

APOE Genotype AD ADRD
N (%) N HR (95% CI) N HR (95% CI)
Women 8,002 525 1,197
 e2/e2 & e2/e3 805 (10%) 44 0.98 (0.71-1.36) 109 0.95 (0.77-1.17)
 e3/e3 4,962 (62%) 254 1.0 (ref) 649 1.0 (ref)
 e2/e4 & e3/e4 2,045 (26%) 204 2.22 (1.84-2.69) 390 1.67 (1.47-1.91)
 e4/e4 190 (2%) 23 3.43 (2.22-5.29) 49 3.00 (2.23-4.03)
 P-trend for genotype < 0.0001 < 0.0001
Men 8,014 495 1,251
 e2/e2 & e2/e3 837 (10%) 33 0.72 (0.50-1.03) 115 0.89 (0.72-1.08)
 e3/e3 5,088 (63%) 270 1.0 (ref) 709 1.0 (ref)
 e2/e4 & e3/e4 1,935 (24%) 161 1.70 (1.39-2.08) 375 1.48 (1.30-1.68)
 e4/e4 154 (2%) 31 5.20 (3.54-7.64) 52 3.21 (2.41-4.28)
 P-trend for genotype < 0.0001 < 0.0001
P for genotype by sex 0.04 0.63

The sex-stratified Cox proportional hazards regression models were each adjusted for age at cohort entry, age at Medicare follow-up start, and genetic ancestry (genetic ancestry proportion variables for African, East Asian, Native American and Polynesian ancestries, with European ancestry as the reference). Of 16,034 participants with APOE genotype data, 18 were removed for missing genetic ancestry information. The p-trend for the APOE genotype associations was estimated by including a numeric variable for the APOE genotype categories ordered as above, e2/e2 through e4/e4. The p for genotype by sex for the difference in the genotype-AD/ADRD association between women and men was obtained based on the interaction term between sex and the APOE genotype trend variable in a combined Cox regression model for AD or ADRD.